{"id":"https://openalex.org/W2212439164","doi":null,"title":"Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments.","display_name":"Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments.","publication_year":2001,"publication_date":"2001-03-30","ids":{"openalex":"https://openalex.org/W2212439164","mag":"2212439164","pmid":"https://pubmed.ncbi.nlm.nih.gov/12747763"},"language":"en","primary_location":{"id":"pmid:12747763","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12747763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunity","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030911593","display_name":"Bruno Robert","orcid":"https://orcid.org/0000-0001-5573-6945","observed_orcids":["https://orcid.org/0000-0001-5573-6945"]},"institutions":[{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"B Robert","raw_affiliation_strings":["Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland","institution_ids":["https://openalex.org/I97565354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001841343","display_name":"Philippe Guillaume","orcid":"https://orcid.org/0000-0002-6340-0963","observed_orcids":["https://orcid.org/0000-0002-6340-0963"]},"institutions":[{"id":"https://openalex.org/I2802229882","display_name":"Centre Hospitalier Universitaire Vaudois","ror":"https://ror.org/05a353079","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"P Guillaume","raw_affiliation_strings":["2Multidisciplinary Oncology Center, University Hospital (CHUV), CH-1011 Lausanne, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Multidisciplinary Oncology Center, University Hospital (CHUV), CH-1011 Lausanne, Switzerland","institution_ids":["https://openalex.org/I2802229882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039715549","display_name":"Immanuel F. Luescher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117758","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02cn3rm21","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I4210117758","https://openalex.org/I4210150094"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"I Luescher","raw_affiliation_strings":["3Ludwig Institute for Cancer Research, Lausanne Branch, CH-1066 Epalinges, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Ludwig Institute for Cancer Research, Lausanne Branch, CH-1066 Epalinges, Switzerland","institution_ids":["https://openalex.org/I4210117758"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056447944","display_name":"Marie\u2010Agn\u00e8s Doucey","orcid":"https://orcid.org/0000-0003-4168-8000","observed_orcids":["https://orcid.org/0000-0003-4168-8000"]},"institutions":[{"id":"https://openalex.org/I4210117758","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02cn3rm21","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I4210117758","https://openalex.org/I4210150094"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M A Doucey","raw_affiliation_strings":["3Ludwig Institute for Cancer Research, Lausanne Branch, CH-1066 Epalinges, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Ludwig Institute for Cancer Research, Lausanne Branch, CH-1066 Epalinges, Switzerland","institution_ids":["https://openalex.org/I4210117758"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111465674","display_name":"Jean\u2010Charles Cerottini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117758","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02cn3rm21","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I4210117758","https://openalex.org/I4210150094"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"J C Cerottini","raw_affiliation_strings":["3Ludwig Institute for Cancer Research, Lausanne Branch, CH-1066 Epalinges, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Ludwig Institute for Cancer Research, Lausanne Branch, CH-1066 Epalinges, Switzerland","institution_ids":["https://openalex.org/I4210117758"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101424852","display_name":"Pedro J. Romero","orcid":"https://orcid.org/0000-0002-9688-2882","observed_orcids":["https://orcid.org/0000-0002-9688-2882","https://orcid.org/0000-0002-6995-5193"]},"institutions":[{"id":"https://openalex.org/I2802229882","display_name":"Centre Hospitalier Universitaire Vaudois","ror":"https://ror.org/05a353079","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882"]},{"id":"https://openalex.org/I4210117758","display_name":"Ludwig Cancer Research","ror":"https://ror.org/02cn3rm21","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I4210117758","https://openalex.org/I4210150094"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"P Romero","raw_affiliation_strings":["4Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), CH-1011 Lausanne, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), CH-1011 Lausanne, Switzerland","institution_ids":["https://openalex.org/I2802229882","https://openalex.org/I4210117758"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109055303","display_name":"Jean\u2010Pierre Mach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272759","display_name":"ISREC Foundation","ror":"https://ror.org/04p69na38","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I4405272759"]},{"id":"https://openalex.org/I97565354","display_name":"University of Lausanne","ror":"https://ror.org/019whta54","country_code":"CH","type":"education","lineage":["https://openalex.org/I97565354"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"J P Mach","raw_affiliation_strings":["1Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland","5Swiss Institute for Experimental Cancer Research, ISREC, CH-1066 Epalinges, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland","institution_ids":["https://openalex.org/I97565354"]},{"raw_affiliation_string":"5Swiss Institute for Experimental Cancer Research, ISREC, CH-1066 Epalinges, Switzerland","institution_ids":["https://openalex.org/I4405272759"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6278,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.63764469,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"1","issue":null,"first_page":"2","last_page":"2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.8880000114440918},{"id":"https://openalex.org/keywords/fab-fragment","display_name":"Fab fragment","score":0.5860000252723694},{"id":"https://openalex.org/keywords/hla-a2","display_name":"HLA-A2","score":0.7699999809265137},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.7179999947547913},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.4970000088214874},{"id":"https://openalex.org/keywords/ctl-activation","display_name":"CTL activation","score":0.6520000100135803},{"id":"https://openalex.org/keywords/tumor-cell-lysis","display_name":"tumor cell lysis","score":0.8460000157356262},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.8732054829597473},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6324794888496399},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6103960871696472},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5250958204269409},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4993174076080322},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.47804003953933716},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.47611838579177856},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4679877460002899},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.44904789328575134},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4482094943523407},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.44074946641921997},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4301183819770813},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.4260209798812866},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4173971712589264},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.36641746759414673},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34190839529037476},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2432219386100769},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23950251936912537},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.19964957237243652},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19349819421768188}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014763","descriptor_name":"Viral Matrix Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015789","descriptor_name":"HLA-A2 Antigen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015789","descriptor_name":"HLA-A2 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018920","descriptor_name":"Coculture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"pmid:12747763","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12747763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunity","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unil.ch:iris/44242","doi":null,"is_oa":false,"landing_page_url":"https://iris.unil.ch/handle/iris/44242","pdf_url":null,"source":{"id":"https://openalex.org/S7407055444","display_name":"IRIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:iris.unil.ch:iris/88672","doi":null,"is_oa":false,"landing_page_url":"https://iris.unil.ch/handle/iris/88672","pdf_url":null,"source":{"id":"https://openalex.org/S7407055444","display_name":"IRIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:serval.unil.ch:BIB_18969","doi":null,"is_oa":false,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_18969","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Immun, vol. 1, pp. 2","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:serval.unil.ch:BIB_1D11A06E45B0","doi":null,"is_oa":false,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_1D11A06E45B0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Immunity, vol. 1, no. 2, pp. 1-13","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2212439164","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12747763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W60759546","https://openalex.org/W1480451944","https://openalex.org/W1481172479","https://openalex.org/W1521600055","https://openalex.org/W1599999513","https://openalex.org/W1807410736","https://openalex.org/W1915689252","https://openalex.org/W1964322434","https://openalex.org/W1980489359","https://openalex.org/W1993191461","https://openalex.org/W1995138538","https://openalex.org/W2001968719","https://openalex.org/W2006174096","https://openalex.org/W2009714185","https://openalex.org/W2018227907","https://openalex.org/W2020229204","https://openalex.org/W2021054875","https://openalex.org/W2031482359","https://openalex.org/W2033094228","https://openalex.org/W2040074861","https://openalex.org/W2041012526","https://openalex.org/W2042174530","https://openalex.org/W2044094798","https://openalex.org/W2050253058","https://openalex.org/W2053104174","https://openalex.org/W2053849689","https://openalex.org/W2057179363","https://openalex.org/W2065272367","https://openalex.org/W2067069532","https://openalex.org/W2076350188","https://openalex.org/W2082117763","https://openalex.org/W2105600427","https://openalex.org/W2107017278","https://openalex.org/W2111239593","https://openalex.org/W2123167369","https://openalex.org/W2125892315","https://openalex.org/W2126061030","https://openalex.org/W2129134079","https://openalex.org/W2131837061","https://openalex.org/W2159459001","https://openalex.org/W2163295981","https://openalex.org/W2165142928","https://openalex.org/W2167008563","https://openalex.org/W2230829804","https://openalex.org/W2254396289","https://openalex.org/W3021254998"],"related_works":["https://openalex.org/W2797453054","https://openalex.org/W7005348122","https://openalex.org/W2021054875","https://openalex.org/W1480451944","https://openalex.org/W2587741111","https://openalex.org/W2063734356","https://openalex.org/W1966593050","https://openalex.org/W2592273195","https://openalex.org/W2150505383","https://openalex.org/W2170449321"],"abstract_inverted_index":{"To":[0],"combine":[1],"the":[2,6,17,28,51,58,76,80],"advantage":[3],"of":[4,10,21,30,93,110,118],"both":[5],"tumor":[7,42,73,87],"targeting":[8],"capacity":[9],"high":[11],"affinity":[12],"monoclonal":[13],"antibodies":[14],"(mAbs)":[15],"and":[16,85,100,122],"potent":[18],"killing":[19],"properties":[20],"cytotoxic":[22],"T":[23,123],"lymphocytes":[24],"(CTL),":[25],"we":[26],"investigated":[27],"activity":[29],"conjugates":[31,63,81,112],"made":[32],"by":[33],"coupling":[34],"single":[35],"Fab'":[36],"fragments,":[37],"from":[38],"mAbs":[39],"specific":[40,99],"for":[41],"cell":[43,88],"surface":[44,95],"antigens,":[45],"to":[46,72],"monomeric":[47],"HLA-A2":[48],"complexes":[49],"containing":[50],"immunodominant":[52],"influenza-matrix":[53],"peptide":[54],"58-66.":[55],"In":[56],"solution,":[57],"monovalent":[59],"95":[60],"kDa":[61],"Fab-HLA-A2/Flu":[62],"did":[64],"not":[65],"activate":[66],"influenza-specific":[67],"CTL.":[68],"However,":[69],"when":[70],"targeted":[71],"cells":[74],"expressing":[75],"relevant":[77],"tumor-associated":[78],"antigen,":[79],"induced":[82],"CTL":[83],"activation":[84],"efficient":[86],"lysis,":[89],"as":[90],"a":[91,115],"result":[92],"MHC/peptide":[94],"oligomerization.":[96],"The":[97],"highly":[98],"sensitive":[101],"in":[102],"vitro":[103],"cytotoxicity":[104],"results":[105],"presented":[106],"suggest":[107],"that":[108],"injection":[109],"Fab-MHC/peptide":[111],"could":[113],"represent":[114],"new":[116],"form":[117],"immunotherapy,":[119],"bridging":[120],"antibody":[121],"lymphocyte":[124],"attack":[125],"on":[126],"cancer":[127],"cells.":[128]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}